Skip to main content
Silva Arslanian, MD, Endocrinology, Pittsburgh, PA

Silva A Arslanian MD

Diabetes, Pediatric Endocrinology


Professor of Pediatrics, University Pittsburgh

Join to View Full Profile
  • 3705 5th AvePittsburgh, PA 15213

  • Phone+1 412-692-5170

  • Fax+1 412-692-8531

Dr. Arslanian is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • UPMC Medical Education
    UPMC Medical EducationFellowship, Pediatric Endocrinology, 1980 - 1984
  • American University of Beirut Faculty of Medicine
    American University of Beirut Faculty of MedicineClass of 1978

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1982 - 2026
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Endocrinology
    American Board of Pediatrics Pediatric Endocrinology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • Pittsburgh Magazine Castle Connolly, 2005, 2008-2011

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association  
    Silva Arslanian, Fida Bacha, Neil H White, Philip Zeitler, Diabetes Care

Lectures

  • Adipose Tissue Insulin Resistance in Youth on the Spectrum from Normal Weight to Obese and from Normal Glucose Tolerance to Impaired Glucose Tolerance to Type 2 Diabetes 
    European Association for the Study of Diabetes, 47th Annual Meeting, Lisbon, Portugal
  • Journal of Pediatrics 
    47th Annual Meeting, Lisbon, Portugal
  • Journal of Pediatrics 
    Pittsburgh, PA - 6/13/2014
  • Join now to see all

Press Mentions

  • FDA-Approved Weight Loss Drug for Adults Successful in Children
    FDA-Approved Weight Loss Drug for Adults Successful in ChildrenNovember 16th, 2022
  • Weight-Loss Drug, Approved for Adults, Shows Promise in Kids
    Weight-Loss Drug, Approved for Adults, Shows Promise in KidsNovember 11th, 2022
  • Semaglutide Reduces BMI More Than Lifestyle Changes in Teens with Obesity
    Semaglutide Reduces BMI More Than Lifestyle Changes in Teens with ObesityNovember 3rd, 2022
  • Join now to see all

Grant Support

  • Administrative supplement to "Brain Health across the Metabolic Spectrum in Youth at risk for T2D"WASHINGTON UNIVERSITY2021–2026
  • Administrative supplement to "Brain Health across the Metabolic Spectrum in Youth at risk for T2D"WASHINGTON UNIVERSITY2021–2026
  • Brain Health Across the Metabolic Continuum in Youth at Risk for T2DWASHINGTON UNIVERSITY2021–2026
  • Insulin Resistance In ChildhoodEunice Kennedy Shriver National Institute Of Child Health &Human Development2009–2011
  • Childhood Metabolic Markers Of Adult Morbidity In BlacksEunice Kennedy Shriver National Institute Of Child Health &Human Development2008–2009
  • Insulin Resistance In ChildhoodEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2008
  • Childhood Metabolic Markers Of Adult Morbidity In BlacksEunice Kennedy Shriver National Institute Of Child Health &Human Development1997–2008
  • Research And Academic Training In Pediatric DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2007
  • Type 2 Diabetes In YOUTH: Beta Cell PreservationNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2007
  • Studies To Treat Or Prevent Pediatric Type 2 Diabetes (Stopp-T2d)National Center For Research Resources2005
  • Academic Career Development In Pediatric Diabetes(K12)National Institute Of Diabetes And Digestive And Kidney Diseases2003–2005
  • Childhood Metabolic Markers Of Adult Morbidity In BlacksNational Center For Research Resources1996–2005
  • Higher IGF1 In Black Vs. White Children: Does Ghrelin Play A Role?National Center For Research Resources2004
  • Physical &Metabolic Characteristics Of Hair An &Pcos In ChildrenNational Center For Research Resources1999–2002
  • Anabolic Effects Of Dihydrotestosterone-- Role Of GHNational Center For Research Resources1999–2002
  • Energy Metabolism And Insulin Resistance During PubertyNational Center For Research Resources1993–1999
  • Pathogenesis Of Glucose Intolerance In Cystic FibrosisNational Center For Research Resources1994–1996
  • Energy Metabolism And Insulin Resistance During PubertyEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1995
  • Pathogenesis Of Glucose Intolerance In Cystic Fibrosis (CF) PatientsNational Center For Research Resources1990–1993
  • Grf-44 Treatment Of Growth Hormone Deficient ChildrenNational Center For Research Resources1990

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: